Full name
PREFARM SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
47.73.Z - Retail sale of pharmaceutical products
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
68 - Real estate activities
73 - Advertising, market research and public relations
77 - Rental and leasing
82 - Office administrative support activities and other business support services
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | 0,3 | 0,4 | 0,5 | 13,3 |
Gross profit (loss) | 0,3 | 0,4 | 0,5 | 16,7 |
EBITDA | 0,3 | 0,4 | 0,5 | 16,2 |
Short time liabilities | 0,1 | 0,2 | 0,2 | -3,3 |
Other operating costs | 0 | 0 | 0 | -94,1 |
Equity capital | 0,3 | 0,4 | 0,6 | 27,5 |
Operating profit (EBIT) | 0,3 | 0,4 | 0,5 | 16,7 |
Assets | 0,5 | 0,7 | 0,8 | 15,9 |
Net profit (loss) | 0,3 | 0,4 | 0,5 | 16,5 |
Cash | 0,2 | 0,4 | 0,4 | 19,2 |
Liabilities and provisions for liabilities | 0,2 | 0,3 | 0,2 | -3,8 |
Net income from sale | 3 | 3,8 | 4,5 | 17,1 |
Working assets | 0,4 | 0,7 | 0,8 | 15,9 |
Other income costs | 0 | 0 | 0 | 18,5 |
Depreciation | 0 | 0 | 0 | -100 |
% | % | % | p.p. | |
Profitability of capital | 96,6 | 90,6 | 82,8 | -7,8 |
Equity capital to total assets | 63 | 63,1 | 69,4 | 6,3 |
Gross profit margin | 10,3 | 11,3 | 11,2 | -0,1 |
EBITDA Margin | 10,4 | 11,3 | 11,2 | -0,1 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 14 | 21 | 17 | -4 |
Current financial liquidity indicator | 3.9555230140686035 | 3.1084518432617188 | 3.726635694503784 | 0,6 |
Net dept to EBITDA | -0.6049028635025024 | -0.7857285737991333 | -0.8168109655380249 | 0 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane